Navigation Links
Melanomas on Scalp and Neck More Deadly
Date:4/21/2008

Survival rate was lower than with malignancies diagnosed on face, ears, study finds

MONDAY, April 21 (HealthDay News) -- The most deadly melanoma skin cancers occur on the scalp and neck, says a University of North Carolina at Chapel Hill (UNC) study.

Researchers analyzed 51,704 melanoma cases in the United States and found that patients with scalp or neck melanomas died at 1.84 times the rate of patients with melanoma elsewhere on the body, including the face or ears.

The five-year survival rate for patients with scalp-neck melanomas was 83 percent, compared with 92 percent for patients with melanomas at other sites. The 10-year survival rate was 76 percent for scalp-neck melanomas and 89 percent for other melanomas.

The findings confirm that melanoma patient survival rates differ depending on where the cancer first appeared, the researchers said. The study was published in the April issue of the Archives of Dermatology.

Doctors need to pay close attention to the scalp when examining patients for signs of skin cancer, said senior author Dr. Nancy Thomas, an associate professor of dermatology in the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center.

"Only 6 percent of melanoma patients present with the disease on the scalp or neck, but those patients account for 10 percent of melanoma deaths. That's why we need to take extra time to look at the scalp during full-skin examinations," Thomas said in a prepared statement.

There has been debate about whether scalp and neck melanoma is more deadly primarily because it's diagnosed later than melanomas in other locations, but this study indicates that the presence of melanoma on the scalp or neck is, in itself, an indicator of poorer patient prognosis.

"We think there's something different about scalp and neck melanomas. This gives us directions for research to look at tumor cell types in those areas at the molecular level and to see if there are differences. I'm interested in identifying the mutations that drive malignancy," Thomas said.

The patients included in study were non-Hispanic white adults in nine states who were first diagnosed with invasive melanoma between 1992 and 2003. Patients with scalp-neck melanomas were more likely to be male and were an average age of 59 years, compared to 55 years for those with other melanomas.

Scalp-neck melanomas were thicker (0.8 millimeters) than other melanomas (0.6 millimeters) and more likely to be ulcerated. The study also found that lymph node involvement was more common in cases of scalp-neck melanomas.

More information

The American Academy of Family Physicians has more about melanoma.



-- Robert Preidt



SOURCE: University of North Carolina at Chapel Hill, news release, April 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Melanomas may appear noticeably different than other moles
2. Melanomas Present Unique Appearance
3. Drug Proves Effective in Slowing Melanomas
4. Scientists Probe Sepsis Deadly Secrets
5. HIV denialists spread misinformation online -- consequences could be deadly; and more
6. Greeks get space-based help in wake of deadly fires
7. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
8. Drug combination might offer hope for patients deadly brain tumors
9. MARCOR Responds to Deadly MRSA Outbreak
10. Common virus may help doctors treat deadly brain tumors
11. A new key to detecting deadly aortic aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company ... with school-aged children since the holiday season. , “It happens every year around ... sharing hugs and taking photos, which is the head-to-head gateway that lice need to ...
(Date:1/20/2017)... ... 2017 , ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation ... trial has been life-saving as she has been on the trial for more ... diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a year later ...
(Date:1/20/2017)... ... ... Magdalene: Grace is Greater than Sin”: a unique and memorable piece of literature ... Grace is Greater than Sin” is the creation of published author, Brenda Roberts, a ... had little knowledge of the female characters portrayed in the Holy Bible. , ...
(Date:1/20/2017)... ... ... examination of how God handles sin, including how to let go of lingering guilt and ... ten long years has been waiting to release this powerful insight about forgiveness that the ... the Lord for over twenty years, and he has been preaching and teaching the Word ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... ARMO BioSciences, Inc., a late-stage immuno-oncology company, ... lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) at the ... of Clinical Oncology (ASCO), taking place January 19-21, 2017 ... "AM0010 induces the expansion of novel T ... in the blood and tumors of our patients," said ...
(Date:1/20/2017)... , Jan 20, 2017 Research ... Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, ... By End-use, And Segment Forecasts, 2013 - 2024" report to ... ... 198.5 billion by 2024 Introduction of innovative solutions on ...
(Date:1/20/2017)... DUBLIN , Jan 20, 2017 ... Pharmaceutical Stability Testing Market Trends, Opportunities, and Future" report to ... ... market sizing, emerging trends, and technologies, and provides a snapshot of ... year is 2015 and forecasts are provided from 2016 to 2020. ...
Breaking Medicine Technology: